• 407-549-3929
  • info@gapsos.com

53. Role of Vascular Endothelial Growth Factor Receptor Inhibitors in Refractory Cervical Cancer.


This review article focuses on the past and future aspects of vascular endothelial growth factor inhibitors in Cervical Cancer.Vascular endothelial growth factor (VEGF)-mediated angiogenesis is considered to play a vital function in the tumor development and metastasis. Therefore, VEGF-inhibitors are being actively considered as prospective anticancer treatment. The most widely studied tyrosine kinase inhibitors that target VEGF or anti- VEGF monoclonal antibodies and receptors, promise significant results in clinical trials.

Key words:Vascular Endothelial Growth Factor; Tyrosine Kinase Inhibitor; Angiogenesis; Human Papilloma Virus; Anti-Angiogenesis Factor.


Complete version…

14 Responses

  1. A formidable share, I just given this onto a colleague who was doing a little analysis on this. And he in truth bought me breakfast because I discovered it for him.. smile. So let me reword that: Thnx for the treat! However yeah Thnkx for spending the time to discuss this, I feel strongly about it and love reading more on this topic. If possible, as you develop into expertise, would you thoughts updating your blog with extra details? It is highly helpful for me. Massive thumb up for this blog put up!

Leave a Reply